|
Thrombophilic tests |
||
| Thrombophilic tests (units of measurement) |
Results |
Normal range |
|
|
||
| Protein C (antigen) (%) |
99% |
60–125 |
| Protein S (antigen) (%) |
102% |
60–125 |
| Antithrombin (activity) (%) |
105% |
80–120 |
| Activated protein C resistance (Bertina) |
0,90 |
>0,77 |
| Anti-cardiolipin antibodies IgG (U/GPL) |
4 |
<7 |
| Anti-cardiolipin antibodies IgM (U/MPL) |
2 |
<4 |
| Lupus anticoagulant |
absent |
absent |
| Plasminogen activator inhibitor type 1 (ng/dl) |
30 |
4–44 |
| PTHRA20210 gene polimorphism |
wild type |
wild type |
| Factor V Leiden gene polimorphism |
wild type |
wild type |
| Apolipoprotein B gene polimorphism C9774T and G3775A |
wild type |
wild type |
| Apolipoprotein E gene polimorphism C3932T and C4070T |
wild type |
wild type |
| Methylene-tetrahydrofolate C677T gene polimorphism |
heterozigosity |
wild type |
| Angiotensin converting enzyme deletion gene polimorphism |
insertion/deletion |
insertion/insertion |
| Homocysteinemia (μM) |
22 |
5–15 |
| Prothrombin time (INR) |
0.95 |
0.8–1.2 |
| Activated partial thromboplastin time (ratio) |
0.92 |
0.8–1.2 |
| Fibrinogen (mg/dl) |
305 |
220–400 |
| D-dimer (ug/l) |
188 |
0–198 |
Granata et al. Thrombosis Journal 2004 2:10 doi:10.1186/1477-9560-2-10 |
||